'Goldmine' U.K. study may hint why Israel has had a larger issue with waning vaccine protection
A "goldmine" of data published by Public Health England on Tuesday provides a look at who may need COVID-19 booster shots, the Financial Times' John Burn-Murdoch reports.
Breaking down the numbers in a series of charts, Burn-Murdoch explains that both the Pfizer-BioNTech and AstraZeneca vaccines, which are the predominant shots in the United Kingdom, have generally held up well against symptomatic coronavirus infections, hospitalizations, and deaths even as the Delta variant took over. There are indications of waning immunity over time, though the declines are more significant among older people and especially older people with underlying health conditions.
That left Burn-Murdoch with two major takeaways. The study simultaneously suggests that "not everyone needs a booster" and that an extra dose "could make a big difference" for those with comorbidities.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
That idea seems to contrast with what's happening in Israel. The country is encouraging everyone regardless of additional factors, to get a third dose of the Pfizer vaccine (and they're even preparing for the possibility of a fourth) because of more drastic signs of waning immunity. But Burn-Murdoch argues the new data backs up the theory that a longer interval between doses deployed by the U.K. sets the stage for better long-term protection than the shorter break taken by Israel and the United States.
The good news is that Israel's booster campaign is working well, so it's worth keeping an eye on what that says about maximizing vaccine efficacy going forward.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Are 'judge shopping' rules a blow to Republicans?
Today's Big Question How the abortion pill case got to the Supreme Court
By Joel Mathis, The Week US Published
-
Climate change is driving Indian women to choose sterilization
under the radar Faced with losing their jobs, they are making a life-altering decision
By Theara Coleman, The Week US Published
-
'A great culture will be lost if the EV brigade gets its way'
Instant Opinion Opinion, comment and editorials of the day
By Harold Maass, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published
-
Anger may be a powerful motivator for tough goals, new study suggests
Speed Read Keeping your cool might actually be less efficient than letting your anger drive you
By Theara Coleman, The Week US Published
-
Malaria is spreading, but we can stop it
The Explainer Climate change is hastening the disease but medicine is catching up
By Devika Rao, The Week US Published